645 SUMMER STREET, BOSTON, MA
Financial Results, Press Release
Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025
Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors
Appoints Christopher D. Brown to its Board of Directors
Submission of Matters to a Vote of Security Holders
Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Initial Statement of Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Specialized Disclosure Report